Related Experiment Videos
The changing face of primary hyperparathyroidism
Journal of the Medical Association of Georgia
|October 1, 1992
Summary
Multiphasic screening and parathormone assays reveal more subclinical primary hyperparathyroidism in older patients. Early detection and surgical intervention are crucial for managing symptoms like osteoporosis and fatigue, even in milder cases.
Area of Science:
- Endocrinology
- Surgical Oncology
Background:
- Multiphasic screening and sensitive parathormone assays have altered the presentation of primary hyperparathyroidism.
- Previous management strategies need re-evaluation due to demographic shifts.
Purpose of the Study:
- To review the changing demographics and clinical features of primary hyperparathyroidism.
- To assess the impact of screening advancements on patient populations.
Main Methods:
- Retrospective review of 158 patients operated on for primary hyperparathyroidism between 1973-1987.
- Comparison of patient data from before 1973 with the study cohort.
Main Results:
- The frequency of subclinical primary hyperparathyroidism increased from 46% to 64%.
- The median patient age rose from 50 to 59 years.
- Common symptoms included osteoporosis, myalgias, fatigue, arthralgias, memory loss, and constipation in 50% of patients.
Conclusions:
- Primary hyperparathyroidism is increasingly diagnosed in an older population.
- Surgical intervention indications for subclinical disease must consider the geriatric population.
- Symptoms often attributed to aging may be exacerbated by hypercalcemia and warrant correction.